Luis Maranga joins Voyager with over 20 years of biotechnology industry experience, focused on bioprocess development, chemistry, manufacturing and controls (CMC), good manufacturing process (GMP), process validation and regulatory submissions, and facilities management including extensive work with the baculovirus/Sf9 expression system. Dr. Maranga most recently served as Vice President, Biologics Development at Bristol-Myers Squibb Company (BMS), where he was responsible for all process and analytical development, and clinical manufacturing from post-discovery to commercial launch for BMS’s biologics programs, and where he also held previously the roles of General Manager, Devens, MA; Biologics Commercial Operations, Site Head for Hopkinton, MA site; and Executive Director, Biologics Manufacturing Sciences and Technology. Prior to BMS, Dr. Maranga served as Head, Technical Development, Viral Vaccines at Novartis, and held senior R&D roles for biologics and vaccines at AstraZeneca/MedImmune and Merck & Co. Dr. Maranga is an expert on biologics, vaccines, and gene therapy CMC development and manufacturing. He holds a Ph.D. in Chemical Engineering from Universidade Nova de Lisboa and a B.S. in Chemical Engineering from the Instituto Superior Tecnico both in Portugal.